🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Andrea Walens

ORCID: 0000-0001-8706-563X
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.367Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Molecular and Clinical Characterization of Postpartum-Associated Breast Cancer in the Carolina Breast Cancer Study Phase I–III, 1993–2013

Cancer Epidemiology Biomarkers & Prevention(2021)10.1158/1055-9965.epi-21-0940
Top 49%
0.367DataRank
Top 49%5 citations

Andrea Walens, Alina M. Hamilton, Mark E. Sherman, Pepper Schedin, Hazel B. Nichols +5 more

Papers

Driven by 8 papers — median percentile 51. Top paper: “Obesity and Breast Cancer Metastasis across Genomic Subtypes”.

Obesity and Breast Cancer Metastasis across Genomic Subtypes

Cancer Epidemiology Biomarkers & Prevention(2022)10.1158/1055-9965.epi-22-0013
N/A
0.373DataRank · unranked
11 citations

Andrea Walens, Alina M. Hamilton, Halei C. Benefield, Jodie M. Fleming, Lisa A. Carey +4 more

Molecular and Clinical Characterization of Postpartum-Associated Breast Cancer in the Carolina Breast Cancer Study Phase I–III, 1993–2013

Cancer Epidemiology Biomarkers & Prevention(2021)10.1158/1055-9965.epi-21-0940
Top 49%
0.367DataRank
Top 49%5 citations

Andrea Walens, Alina M. Hamilton, Mark E. Sherman, Pepper Schedin, Hazel B. Nichols +5 more

Quantitative Profiling of Adaptation to Cyclin E Overproduction

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.07.26.453751
N/A
0.104DataRank · unranked
1 citations

Amiee N. Littlejohn, Amy M. House, Katarzyna M. Kedziora, Brandon L. Mouery, Boyang Ma +6 more

DNA Damage Repair Classifier Defines Distinct Groups in Hepatocellular Carcinoma

Cancers(2022)10.3390/cancers14174282
N/A
0DataRank · unranked
6 citations

Sarah C. Van Alsten, Andrea Walens, Jeffrey S. Damrauer, Ugwuji N. Maduekwe, Russell R. Broaddus +4 more

The TRIM69-MST2 signaling axis regulates centrosome dynamics and chromosome segregation

Nucleic Acids Research(2023)10.1093/nar/gkad766
N/A
0DataRank · unranked
10 citations

Patrik Risteski, Yang Yang, Huan Chen, Gaith N. Droby, Andrea Walens +8 more

Diffsig: Associating Risk Factors with Mutational Signatures

Cancer Epidemiology Biomarkers & Prevention(2024)10.1158/1055-9965.epi-23-0728
N/A
0DataRank · unranked
3 citations

Markia A. Smith, Sarah C. Van Alsten, Andrea Walens, Di Wu, Katherine A. Hoadley +3 more

Investigating survivin as a novel target in black women with breast cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.594
N/A
0DataRank · unranked
0 citations

Linnea T. Olsson, Sarah Van Alsten, Lisa A. Carey, Melissa A. Troester, Yara Abdou +1 more

Quantitative profiling of adaptation to cyclin E overproduction

Life Science Alliance(2022)10.26508/lsa.202201378
N/A
0DataRank · unranked
17 citations

Amiee N. Littlejohn, Amy M. House, Katarzyna M. Kedziora, Brandon L. Mouery, Boyang Ma +6 more